Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulator. (Q44432980)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18362932%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

title

Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulator (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18362932%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18362932%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Joseph R Arron

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18362932%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

2

Gulnar Hafiz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18362932%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1

Peter A Campochiaro

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18362932%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

author name string

Syed Mahmood Shah

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18362932%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Quan Dong Nguyen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18362932%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Howard Ying

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18362932%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Diana V Do

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18362932%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Edward Quinlan

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18362932%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Ingrid Zimmer-Galler

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18362932%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Julia A Haller

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18362932%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Sharon D Solomon

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18362932%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Jennifer U Sung

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18362932%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Yasmin Hadi

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18362932%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Kashif A Janjua

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18362932%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Nida Jawed

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18362932%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

publication date

5 February 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18362932%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18362932%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18362932%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18362932%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

page(s)

791-799

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18362932%20AND%20SRC:MED&resulttype=core&format=json

Natural history and clinical management of central retinal vein occlusion. The Central Vein Occlusion Study Group

4 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.10

7 January 2021

Arteriovenous crossing patterns in branch retinal vein occlusion. The Eye Disease Case-Control Study Group.

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.10

7 January 2021

Argon laser photocoagulation for macular edema in branch vein occlusion. The Branch Vein Occlusion Study Group

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.10

7 January 2021

Intravitreal sustained release of VEGF causes retinal neovascularization in rabbits and breakdown of the blood-retinal barrier in rabbits and primates

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.10

7 January 2021

Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.10

7 January 2021

Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion. The Central Vein Occlusion Study Group M report

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.10

7 January 2021

Ranibizumab for neovascular age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.10

7 January 2021

Ranibizumab versus verteporfin for neovascular age-related macular degeneration.

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.10

7 January 2021

Interventions for central retinal vein occlusion: an evidence-based systematic review

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.10

7 January 2021

Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.10

7 January 2021

Intravitreal bevacizumab (avastin) for central and hemicentral retinal vein occlusions: IBeVO study.

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.10

7 January 2021

Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.10

7 January 2021

Clinical, anatomic, and electrophysiologic evaluation following intravitreal bevacizumab for macular edema in retinal vein occlusion

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.10

7 January 2021

Bevacizumab in retinal vein occlusion-results of a prospective case series

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.10

7 January 2021

Optical coherence tomography

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.10

7 January 2021

Optical coherence tomography of the human retina

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.10

7 January 2021

Normal macular thickness measurements in healthy eyes using Stratus optical coherence tomography.

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.10

7 January 2021

A sensitive fluorometric enzyme-linked immunosorbent assay that measures vascular endothelial growth factor165 in human plasma

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.10

7 January 2021